CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
April 2020—Becton Dickinson and Babson Diagnostics, a diagnostic blood testing company, announced a long-term strategic partnership agreement to bring laboratory-quality, small-volume blood collection to retail pharmacies. BD’s capillary specimen collection devices, in development, are designed to enable the collection of laboratory-quality specimens without the need to access a vein and are for use in health care settings without a trained phlebotomist, such as retail pharmacies, physician offices, urgent care centers, and skilled nursing facilities. Babson’s offerings include proprietary automated sample handling and analytical technologies, which are also in development.
Babson and BD are undertaking clinical studies on these devices in retail pharmacy settings. BD plans to prepare regulatory submissions to the FDA and other global regulatory bodies upon completion of these clinical studies.